Obesity and its comorbid conditions

https://doi.org/10.1016/S1098-3597(99)90002-9Get rights and content

Abstract

Obese patients are at an increased risk for developing many medical problems, including insulin resistance and type 2 diabetes mellitus, hypertension, dyslipidemia, cardiovascular disease, stroke, sleep apnea, gallbladder disease, hyperuricemia and gout, and osteoarthritis. Certain, cancers are also associated with obesity, including colorectal and prostate cancer in men and endometrial, breast, and gallbladder cancer in women (1–6). Excess body weight is also associated with substantial increases in mortality from all causes, in particular, cardiovascular disease. More than 5% of the national health expenditure in the United States is directed at medical costs associated with obesity (7). In addition, certain psychologic problems, including binge-eating disorder and depression, are more common among obese persons than they are in the general population (8,9). Finally, obese individuals may suffer from social stigmatization and discrimination, and severely obese people may experience greater risk of impaired psychosocial and physical functioning causing a negative impact on their quality of life (10).

References (62)

  • A.M. Wolf et al.

    Current estimates of the economic cost of obesity in the United States

    Obes Res.

    (1998)
  • G.D. Foster et al.

    The psychology of obesity, weight loss, and weight regain: research and clinical findings

  • T.A. Wadden et al.

    Psychosocial consequences of weight reduction: how much weight loss is enough?

    Am J Clin Nutr

    (1996)
  • J.P. Foreyt et al.

    The future of obesity treatment

  • W. Willett et al.

    Guidelines for healthy weight

    N Engl J Med.

    (1999)
  • K.M. Flegal et al.

    Overweight and obesity in the United States: prevalence and trend

    Int J Obes Relat Metab Disord

    (1998)
  • A.E. Field et al.

    Weight cycling, weight gain, and risk of hypertension in women

    Am J Epidemiol

    (1999)
  • Z. Huang et al.

    Body weight, weight change, and risk for hypertension in women

    Ann Intern Med.

    (1998)
  • A.R. Dyer et al.

    The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group

    J Hum Hypertens

    (1989)
  • J. Kolanowski

    Obesity and hypertension: from pathophysiology to treatment

    Int J Obes Relat Metab Disord

    (1999)
  • J.E. Hall

    Renal and cardiovascular mechanisms of obesity

    Hypertension

    (1994)
  • S. Wassertheil-Smoller et al.

    The Trial of Antihypertensive Interventions and Management (TAIM) Study: Adequate weight loss, alone and combined with drug therapy, in the treatment of mild hypertension

    Arch Intern Med

    (1992)
  • S. MacMahon et al.

    Obesity and hypertension: epidemiological and clinical issues

    Eur Heart J

    (1987)
  • E. Reisin

    Weight reduction in the management of hypertension: epidemiologic and mechanistic evidence

    Can J Physiol Pharmacol

    (1986)
  • M.L. Tuck et al.

    The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

    N Engl J Med

    (1981)
  • E. Reisin et al.

    Cardiovascular changes after weight reduction in obesity hypertension

    Ann Intern Med.

    (1983)
  • G.A. Colditz et al.

    Weight gain as a risk factor for clinical diabetes mellitus in women

    Ann Intern Med.

    (1995)
  • J. Chan et al.

    Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men

    Diabetes Care

    (1994)
  • W.C. Knowler et al.

    Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes

    Am J Epidemiol

    (1981)
  • E.T. Lee et al.

    Diabetes and impaired glucose tolerance in three American Indian populations aged 45–74 years. The Strong Heart Study

    Diabetes Care

    (1995)
  • G.I. Shulman

    Cellular mechanisms of insulin resistance in humans

    Am J Cardiol.

    (1999)
  • Cited by (304)

    • The influence of epigenetics and inflammation on cardiometabolic risks

      2024, Seminars in Cell and Developmental Biology
    View all citing articles on Scopus
    View full text